Kraj: Australia
Język: angielski
Źródło: Department of Health (Therapeutic Goods Administration)
Japanese encephalitis virus
Sanofi-Aventis Australia Pty Ltd
Medicine Registered
SANOFI PASTEUR AUSTRALIAN CMI, V 1.1 JE-CV AUSTRALIAN CONSUMER MEDICINE INFORMATION IMOJEV ® Japanese encephalitis vaccine (live, attenuated) WHAT IS IN THIS LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU OR YOUR CHILD IS VACCINATED. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This vaccine has been prescribed for you or your child. Do not pass it on to others. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: What IMOJEV ® is and what it is used for Before you or your child is given IMOJEV ® How IMOJEV ® is given Possible side effects Storing IMOJEV ® Further information WHAT IMOJEV ® IS AND WHAT IT IS USED FOR IMOJEV ® is a vaccine that helps to protect you or your child against Japanese encephalitis. The vaccine may be administered to persons of 12 months of age and over. When an injection of IMOJEV ® is given, the immune system (body’s natural defences) will protect against Japanese encephalitis infection. However, as with all vaccines, 100% protection cannot be guaranteed. In adults, IMOJEV ® will generally begin protecting against Japanese encephalitis 2 weeks after the injection. In children, IMOJEV ® will generally begin protecting against Japanese encephalitis 4 weeks after the injection. PAGE 1 OF 6 SANOFI PASTEUR AUSTRALIAN CMI, V 1.1 JE-CV IMOJEV ® will not prevent Japanese encephalitis if you or your child is incubating the disease before vaccination or if the encephalitis is caused by another virus. BEFORE YOU OR YOUR CHILD IS GIVEN IMOJEV ® _WHO SHOULD NOT RECEIVE IMOJEV_ ® _ _ If you or your child is allergic (hypersensitive) to the active substance or any of the other ingredi Przeczytaj cały dokument